How did BPC 157 become the wellness industry's star peptide? FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System Sample of patents with BPC 157 utilization. Download Scientific Diagram